Biofrontera Inc. ( BFRI) - Stock Earnings
BFRI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -6.6 million USD | 7.0 million USD |
| 2025Q4 | 5.6 million USD | 17.1 million USD |
| 2026Q1 | -4.8 million USD | 10.1 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
BFRI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -20.1 million USD | 34.1 million USD |
| 2024 | -17.8 million USD | 37.3 million USD |
| 2025 | -10.5 million USD | 41.7 million USD |
| 2026 Est. | — | — |
BFRI
Price: $1
52 week price:
Earnings Per Share: -0.98 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 345400
Market Capitalization: 9.6 million